Startups

Alzheimer's Drug Discovery Foundation
New York, NY, United States
The Alzheimer’s Drug Discovery Foundation (ADDF) is a US public charity using venture philanthropy and mission-related investments to advance drugs, diagnostics and prevention for Alzheimer’s disease and related dementias. Its scientific portfolio includes fluid, retinal and digital/AI biomarkers, clinical trials and neurotherapeutics; financial returns are reinvested in its mission. The Delaware nonprofit was incorporated in April2004 (EIN20-1082179), with the Lauder family’s earlier Alzheimer’s research philanthropy as historical context. It is a 501(c)(3) public charity, not a conventional VC manager or private foundation. The current staff directory names IsobelColeman CEO and LauraNisenbaum interimCSO; HowardFillit is cofounder/CSO emeritus. DiagnosticsAccelerator, launchedJuly2018, reports100MUSD philanthropic commitments, not an LP fund close or proof allpledges have been paid. The audited2024 statements distinguish approved contracted mission-related investment payables from cash received/paid and report financial returns only when received. The published team includes staff, governors, overseers and clearly marked honorary/in-memoriam affiliations; these are not all operating employees.




















































